Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Website Tools
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Therapeutic Development Services

Interventional Agent Development Services


What services does this resource provide?

The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. Note: Devices are excluded.

Services include

  • Lead identification and development
  • Chemistry and manufacturing
  • In vitro and in vivo preclinical safety, toxicology, and biokinetics
  • Preclinical development, planning, and evaluation

See examples of services within each of these categories.

A suite of services is provided to support the development of products directed against the full range of pathogens, including bacteria, viruses, parasites, fungi, and other agents such as toxins and prion proteins.

Services will be conducted at the appropriate regulatory compliance level dependent on the stage of product development.

Note: Resources are limited and intended to fill critical gaps and are not to be the sole source of product development. Preliminary data to support program participation are required.



Last Updated March 05, 2014